Search results
Chinese zoo under fire after dyeing dogs to resemble pandas
NBC News via Yahoo News· 6 days agoHONG KONG — A zoo in China has been accused of trying to deceive visitors with a pair of dogs dyed...
Opinion | Sino-US youth exchanges are vital – and Hong Kong has a role to play
South China Morning Post· 1 day agoSecondly, taking a youth-oriented angle to Sino-American dialogue circumvents the more politicised...
Opinion | Death of Hong Kong hepatitis B sufferer a reminder to put patient safety first
South China Morning Post· 1 day agoTang was treated for kidney disease at United Christian Hospital and given a heavy dose of steroids....
SEHK Growth Companies With High Insider Ownership And Earnings Growth Up To 55%
Simply Wall St. via Yahoo Finance· 3 days agoAmid a backdrop of fluctuating global markets, Hong Kong's Hang Seng Index has recently shown...
HUTCHMED begins trial of combination therapy for pancreatic ductal adenocarcinoma
Clinical Trials Arena via Yahoo Finance· 2 days agoHong Kong-based biopharmaceutical company HUTCHMED has begun a Phase II/III clinical trial of...
Asia Deal Digest: In Hong Kong, Listings and Privatization Create Small Streams of Work While...
Law.com· 6 days agoThe Asia Deal Digest, published periodically, is a look at some of the largest deals carried out in...
She was Hong Kong’s ‘happy fruit’: the life of ‘Fei Fei’, comedian Lydia Sum
South China Morning Post· 6 days agoThe Cantonese-language production surpassed Bruce Lee’s Enter the Dragon to become the top local...
...FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early...
Rome Sentinel· 1 day agoFood and Drug Administration (FDA) for lecanemab-irmb (U.S. brand name: LEQEMBI®) subcutaneous autoinjector for weekly maintenance dosing after it was granted Fast Track designation by the FDA ...
EHA 2024 | Results from Five Studies of Ascentage Pharma's Key Drug Candidates Selected for...
FOX 5 San Diego· 5 hours agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced ...
Boost for patients with Hong Kong public hospitals to cut drug approval steps
South China Morning Post· 3 days agoThe application would then be submitted to various committees at public hospitals for review before...